← Back
Data updated: Mar 29, 2026
MARINUS
Neurology
Pharma
MARINUS is a pharmaceutical company focused on Neurology. Key products include ZTALMY.
2022
Since
1
Drugs
-
Trials
3
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs Phase 3: 1 Phase 2: 3
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2022-03-18
- Latest
- 2025-10-16
- Applications
- 1